Answers are grounded in this paper and cite their sources.
Vitamin B2 (riboflavin) is one of the essential biomolecules in all forms of life. It is a precursor to redox co-factors riboflavin-5'-mononucleotide (FMN) and flavin adenine dinucleotide (FAD). Previous reports of riboflavin catabolism are sparse, and the enzymes responsible were not identified. We report the first identification and characterization of a complete riboflavin catabolic pathway. A novel flavoenzyme motif in Microbacterium maritypicum cleaves the ribose chain and forms lumichrome, which is not degraded further. Pimelobacter simplex was then found capable of utilizing lumichrome as a carbon and nitrogen source. Metabolic studies coupled with chemical logic led to the identification of a gene cluster and subsequent functional characterization of the enzymes involved in the breakdown of lumichrome into small metabolites. Lumichrome has low water solubility (4.8 mg/L). To increase its availability to cells, the first step of lumichrome catabolism is a rare oxidation of the C7-methyl group by a 'self-sufficient' cytochrome P450, producing more soluble 7-carboxylumichrome. The entire pathway then goes through cascades of oxidative and hydrolytic enzymes to systematically open up each of the three rings of lumichrome. The pathway also includes a unique thiamin pyrophosphate (TPP)-dependent decarboxylase that acts on an aromatic carboxylic acid, an unprecedented reaction for this class of enzymes. The mechanism of this enzyme is currently being studied using substrate analogs and intermediate trapping. The final steps involve a metal-dependent hydroxylation by a cupin-domain containing hydratase before a retro-aldolase produces pyruvic acid (used in the Krebs citric acid cycle) and acetoacetate. Characterization of the entire riboflavin catabolic pathway will lead to a further understanding of how bacterial catabolism can be responsible for vitamin deficiencies, elucidating possible druggable targets. This research was funded by the Welch foundation.
No takes yet. Share an insight, caveat, or question.
Sinha et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: